ArticleMolecular imaging and biology2023

Early Reduction of Glucose Consumption Is a Biomarker of Kinase Inhibitor Efficacy Which Can Be Reversed with GLUT1 Overexpression in Lung Cancer Cells.

Chiara Ghezzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.